BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8083120)

  • 1. Breast conservation for ductal carcinoma in situ: what is the risk?
    Morrow M
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):235-6. PubMed ID: 8083120
    [No Abstract]   [Full Text] [Related]  

  • 2. Despite limited data, coexistent lobular carcinoma in situ should not be a contraindication to breast conservation for women with invasive breast carcinoma.
    Bear HD; Carter WH; Grimes MM
    Cancer; 2000 Mar; 88(5):978-81; discussion 982-3. PubMed ID: 10699883
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease.
    Atkins CD
    J Natl Cancer Inst; 1998 Jan; 90(2):160-2. PubMed ID: 9450579
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast conservation therapy in the management of invasive and in situ carcinoma.
    Masko GB; Triedman SA; Brotman RL; Webber BM; Yu A
    R I Med; 1995 Sep; 78(9):246-9. PubMed ID: 7579719
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of ductal carcinoma in situ.
    Mokbel K; Wells C; Carpenter R
    N Engl J Med; 1999 Sep; 341(13):998-9; author reply 1000. PubMed ID: 10498500
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of ductal carcinoma in situ.
    Heimann R; Karrison T; Hellman S
    N Engl J Med; 1999 Sep; 341(13):999-1000. PubMed ID: 10498502
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of ductal carcinoma in situ.
    Harries SA; Johnston AO; Parker SJ
    N Engl J Med; 1999 Sep; 341(13):999; author reply 1000. PubMed ID: 10498501
    [No Abstract]   [Full Text] [Related]  

  • 8. Predicting residual disease and local recurrence in patients with ductal carcinoma in situ.
    Silverstein MJ
    J Natl Cancer Inst; 1997 Sep; 89(18):1330-1. PubMed ID: 9308697
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histological margin and residual disease assessment for breast carcinoma].
    Sigal-Zafrani B; Fourquet A; Vincent-Salomon A; Fréneaux P; Génin P; Rosty C; Sastre-Garau X
    Cancer Radiother; 2003 Nov; 7 Suppl 1():120s-123s. PubMed ID: 15124553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: intraductal carcinoma (ductal carcinoma in situ).
    Antoniades K
    Cancer; 1995 Dec; 76(11):2385-7. PubMed ID: 8635049
    [No Abstract]   [Full Text] [Related]  

  • 11. Current management of ductal carcinoma in situ.
    Fondrinier E; Lorimier G
    Eur J Surg Oncol; 1998 Apr; 24(2):155-6. PubMed ID: 9591039
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J; Delaney G; Taylor R
    Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery.
    Ohuchi N; Furuta A; Mori S
    Cancer; 1994 Aug; 74(4):1294-302. PubMed ID: 8055451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duct carcinoma in situ: biological implications for clinical practice.
    Lagios MD
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):6-11. PubMed ID: 8614847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal carcinoma in situ.
    Loring L; Dershaw DD
    Crit Rev Diagn Imaging; 1997 Dec; 38(6):501-33. PubMed ID: 9442977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ--the focus for prevention, screening, and breast conservation in breast cancer.
    Page DL; Simpson JF
    N Engl J Med; 1999 May; 340(19):1499-500. PubMed ID: 10320390
    [No Abstract]   [Full Text] [Related]  

  • 17. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?
    Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA
    J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local recurrence of ductal in situ carcinoma of the breast].
    Dunst J
    Strahlenther Onkol; 1999 Jul; 175(7):348-9. PubMed ID: 10432998
    [No Abstract]   [Full Text] [Related]  

  • 19. [Whole-breast irradiation following breast-conserving surgery of ductal carcinomain situ is indispensable. Update of the 2005 DEGRO (German Society of Radiation Oncology) Guideline on Radiation Therapy for Breast Cancer].
    Souchon R; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sautter Bihl ML; Wenz F; Sauer R;
    Strahlenther Onkol; 2006 Aug; 182(8):429-30. PubMed ID: 16896587
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of ductal carcinoma in situ.
    Vicini FA; Kestin LL; Goldstein NS
    N Engl J Med; 1999 Sep; 341(13):998; author reply 1000. PubMed ID: 10498499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.